2) Autosomal dominant polycystic kidney disease
常染色体显性多囊肾病
1.
A Chinese autosomal dominant polycystic kidney disease family probably related to?PKD2 gene;
一个可能与PKD2基因连锁的常染色体显性多囊肾病家系
2.
We combined two dimensional liquid chromatography—tandem mass spectrometry (2D LC-MS/MS) with the method of isotope-coded affinity tag (ICAT) to do comparative analysis between the proteomes of urine, serum and cells from ADPKD patients and normal controls, aiming to find as many proteins as possible which get involved in the pathogenesis of Autosomal dominant polycystic kidney disease (ADPKD).
为尽可能多地寻找与常染色体显性多囊肾病(autosomal dominant polycystic kidney disease,ADPKD)发病相关的蛋白质,我们采用同位素编码的亲和标签技术与二维液相色谱-串联质谱相结合的定量比较蛋白组学方法分别对ADPKD患者与正常成人尿液、血清蛋白质组样品,以及囊肿衬里上皮细胞与正常肾小管上皮细胞的蛋白质组样品进行比较。
3.
Objective:To observe the expression of epidermal growth factor(EGF)and its receptor(EGFR)in the body fluids and renal tissues of rats with autosomal dominant polycystic kidney disease(ADPKD)and to explore their roles in the development of the disease.
目的:观察常染色体显性多囊肾病大鼠体液及肾脏组织中表皮生长因子(EGF)及其受体(EGFR)的表达,探讨二者在多囊肾病发病过程中的作用。
3) ADPKD
常染色体显性多囊肾病
1.
Objective: To investigate the role of celecoxib in the treatment of autosomal dominant polycystic kidney disease(ADPKD).
目的：研究特异性环氧化酶-2抑制剂塞来昔布治疗类似良性肿瘤的常染色体显性多囊肾病(ADPKD)，以阐明该药具有良好的治疗作用。
4) autosomal dominant polycystic kidney disease
常染色体显性遗传性多囊肾病
1.
Objective:To observe the clinical effect of laparoscopic renal cyst decortication in patients with autosomal dominant polycystic kidney disease.
目的:观察经后腹腔镜肾囊肿去顶减压术治疗常染色体显性遗传性多囊肾病的临床效果。
补充资料：多囊肾
多囊肾
polycystic kidney
为先天性肾囊肿病之一。分为成人型及婴儿型两种。前者为常染色体显性遗传；后者为常染色体隐性遗传，并伴有肝脏病变。多囊肾为双肾病变，两肾内散布大小不等囊肿，且囊肿伴随年龄逐渐增大。其临床表现可分为两方面：与囊肿有关的症状如腰部肿物、腰痛、肉眼及镜下血尿及反复泌尿系统感染等；与囊肿压迫肾实质有关的表现，如高血压及肾功能不全。本病常需X线肾盂造影或B型超声检查确诊。多囊肾无有效治疗。防治泌尿系感染及控制高血压对减慢功能衰退具有意义。晚期肾衰可行透析治疗或肾移植。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条